Found 22 matching trials
FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma PHASE2 This study is a prospective, multicenter Phase II trial evaluating a person...
Show More Location
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Learn More & Join Trial
Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge NA The purpose of this study was to prospectively evaluate the efficacy and sa...
Show More Location
Cancer Institute &Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis PHASE2 This study is the first to compare the efficacy and safety of recombinant h...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma PHASE3 Hepatocellular carcinoma (HCC) is the sixth most common cancer and the thir...
Show More Location
Sichuan Cancer Hospital and Research Institute
Learn More & Join Trial
EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial PHASE1 The goal of this clinical trial is to evaluate the efficacy and safety of c...
Show More Location
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery
Learn More & Join Trial
Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004) N/A This study aims to evaluate the safety and efficacy of fecal microbiota tra...
Show More Location
Multiple Locations
Learn More & Join Trial
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome PHASE2 Primary liver cancer is a malignant tumor with a very poor prognosis. Hepat...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH) PHASE2 The goal of this clinical trial is to compare the safety and efficacy of se...
Show More Location
Tuen Mun Hospital
Learn More & Join Trial
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure NA This study is a prospective, randomized controlled, multicenter clinical st...
Show More Location
Multiple Locations
Learn More & Join Trial
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma PHASE1 This study is to evaluate the feasibility and safety of personalized tumor ...
Show More Location
the First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial